MeSH term | MeSH ID | Detail |
---|---|---|
Body Weight | D001835 | 333 associated lipids |
Total
1
Eupatilin is a lipid of Polyketides (PK) class.
We collected disease MeSH terms mapped to the references associated with Eupatilin
MeSH term | MeSH ID | Detail |
---|---|---|
Body Weight | D001835 | 333 associated lipids |
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Zhou K et al. | Eupatilin ameliorates dextran sulphate sodium-induced colitis in mice partly through promoting AMPK activation. | 2018 | Phytomedicine | pmid:30097122 |
Wang X et al. | Eupatilin inhibits the proliferation of human esophageal cancer TE1 cells by targeting the Akt‑GSK3β and MAPK/ERK signaling cascades. | 2018 | Oncol. Rep. | pmid:29693162 |
Song EH et al. | Eupatilin suppresses the allergic inflammatory response in vitro and in vivo. | 2018 | Phytomedicine | pmid:29655675 |
Lv JL et al. | Two new flavonoids from Artemisia argyi with their anticoagulation activities. | 2018 | Nat. Prod. Res. | pmid:28539062 |
Kim M et al. | Cytoprotective effect of eupatilin against indomethacin-induced damage in feline esophageal epithelial cells: relevance of HSP27 and HSP70. | 2018 | Arch. Pharm. Res. | pmid:30109575 |
Wang X et al. | Pharmacokinetics and tissue distribution of eupatilin and its metabolite in rats by an HPLC-MS/MS method. | 2018 | J Pharm Biomed Anal | pmid:29980012 |
Kim JS et al. | Eupatilin inhibits adipogenesis through suppression of PPARγ activity in 3T3-L1 cells. | 2018 | Biomed. Pharmacother. | pmid:29649628 |
Jung Y et al. | Eupatilin, an activator of PPARα, inhibits the development of oxazolone-induced atopic dermatitis symptoms in Balb/c mice. | 2018 | Biochem. Biophys. Res. Commun. | pmid:29353040 |
Choo SH et al. | Effects of eupatilin on the contractility of corpus cavernosal smooth muscle through nitric oxide-independent pathways. | 2017 | Andrology | pmid:28719725 |
Sapkota A et al. | Eupatilin exerts neuroprotective effects in mice with transient focal cerebral ischemia by reducing microglial activation. | 2017 | PLoS ONE | pmid:28178289 |